CTMX - CytomX Therapeutics, Inc.
IEX Last Trade
1.095
0 0%
Share volume: 18,874
Last Updated: Thu 26 Dec 2024 08:29:03 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$1.10
0.00
0.00%
Summary score
24%
Profitability
14%
Dept financing
25%
Liquidity
32%
Performance
31%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-21.35%
Return on assets
-4.38%
Return on sales
-262.22%
Return on invested capital
7.01%
Total debt ratio
97.26%
Debt ratio change over timeo
-6.94%
Current Ratio
2.35%
Quick Ratio
2.35%
Cash Position Ratio
2.26%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-12.46%
Return on assets
1.46%
Return on sales
6.03%
Return on invested capital
-3.23%
Total debt ratio
126.12%
Debt ratio change over timeo
-26.04%
Current Ratio
1.26%
Quick Ratio
1.26%
Cash Position Ratio
1.19%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-43.53%
Return on assets
6.31%
Return on sales
28.11%
Return on invested capital
-10.85%
Total debt ratio
117.15%
Debt ratio change over time
-192.84%
Current Ratio
1.16%
Quick Ratio
1.16%
Cash Position Ratio
1.04%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
491.67%
Return on assets
-175.51%
Return on sales
-1124.23%
Return on invested capital
-22.88%
Total debt ratio
-693.95%
Debt ratio change over time
-6.94%
Current Ratio
-16.6%
Quick Ratio
-16.6%
Cash Position Ratio
-15.53%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CTMX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -21.35% | 13.79% | 34.47% | 7.43% |
| Return on assets | -4.38% | 2.76% | 3.15% | 5.62% |
| Return on sales | -262.22% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 7.01% | 2.36% | 5.39% | 19.77% |
| Profitability | 9% | 43% | 66% | 80% |
| Total debt ratio | 97.26% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -6.94% | 308.97% | -6.99% | 1.18% |
| Dept financing | 25% | 48% | 23% | 7% |
| Current Ratio | 1.26% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.26% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.19% | 0.36% | 1.28% | 2.93% |
| Liquididy | 54% | 14% | 32% | 73% |
| Short-term ratios | CTMX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -12.46% | 13.77% | 13.25% | 3.8% |
| Return on assets | 1.46% | 2.43% | 1.89% | 3.09% |
| Return on sales | 6.03% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -3.23% | 2.14% | 3.39% | 9.18% |
| Profitability | 17% | 71% | 68% | 82% |
| Total debt ratio | 126.12% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -26.04% | 46.38% | -72.08% | 1.51% |
| Dept financing | 25% | 43% | 18% | 5% |
| Current Ratio | 1.26% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 1.26% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 1.19% | 0.36% | 1.28% | 2.93% |
| Liquididy | 23% | 12% | 31% | 75% |